Cargando…

MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes

Introduction Cushing’s syndrome is associated with significant chronic and acute comorbidities including acute thromboembolic and cardiovascular events. To date, there are no data on the prevalence and predictors of acute and perioperative complications in patients with active Cushing’s syndrome. Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Schernthaner-Reiter, Marie Helene, Siess, Christina, Alexander, Micko, Wolfsberger, Stefan, Scheuba, Christian, Riss, Philipp, Knosp, Engelbert, Kautzky-Willer, Alexandra, Luger, Anton, Vila, Greisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208937/
http://dx.doi.org/10.1210/jendso/bvaa046.789
_version_ 1783530963210338304
author Schernthaner-Reiter, Marie Helene
Siess, Christina
Alexander, Micko
Wolfsberger, Stefan
Scheuba, Christian
Riss, Philipp
Knosp, Engelbert
Kautzky-Willer, Alexandra
Luger, Anton
Vila, Greisa
author_facet Schernthaner-Reiter, Marie Helene
Siess, Christina
Alexander, Micko
Wolfsberger, Stefan
Scheuba, Christian
Riss, Philipp
Knosp, Engelbert
Kautzky-Willer, Alexandra
Luger, Anton
Vila, Greisa
author_sort Schernthaner-Reiter, Marie Helene
collection PubMed
description Introduction Cushing’s syndrome is associated with significant chronic and acute comorbidities including acute thromboembolic and cardiovascular events. To date, there are no data on the prevalence and predictors of acute and perioperative complications in patients with active Cushing’s syndrome. Methods In a single-center cohort analysis we evaluate predictors and outcomes of acute, life-threatening and perioperative complications in patients with active biochemically verified Cushing’s syndrome attending our endocrine department between 1978 and 2016. Any medical complications necessitating hospitalization, including admission to intensive care units (ICUs), from the time of appearance of first symptoms of hypercortisolism until one year after biochemical remission by surgery (or where surgical remission was not achieved, during continuing follow-up) were recorded and classified. Baseline factors related to and predicting acute complications were tested using uni- and multivariate analysis. Results The study included 242 patients (m/f n=54/188) with Cushing’s syndrome (pituitary n=99, adrenal n=116, ectopic n=27), 14.0% of which had malignant disease. At least one acute complication was observed in 54.5% of patients; these included electrolyte disturbances (24.4%), infections (27.7%), thromboembolic events (14.9%), cardiac arrhythmias necessitating medical intervention (5.4%), hypertensive crises (8.7%), acute coronary events (3.3%) and cerebrovascular events (4.1%). At least one ICU admission (excluding post-surgical observance) was required in 13.2% of patients. The majority of complications occurred prior to surgery (60-90%); infections occurred pre- and postoperatively (51.7% vs 48.3%, respectively). Patients with ectopic Cushing’s syndrome demonstrated a higher likelihood of infection (p<0.001), hypokalemia (p<0.001) and ICU stays (p=0.009) compared to patients with pituitary or adrenal Cushing’s syndrome. Patients with diabetes mellitus at diagnosis (n=81) had a significantly higher frequency of infection (p<0.001), hypokalemia (p<0.001), hypertensive crises (p=0.004), acute coronary events (p=0.029), arrhythmias (p=0.025) and a higher likelihood of an ICU stay (p<0.001). The total number of acute complications and the number of days at ICU correlated positively with parameters of cortisol excess including urinary free cortisol and the time of hypercortisolism. Conclusion This cohort analysis identifies a significantly high prevalence of acute and perioperative complications in Cushing’s syndrome, with one in eight patients suffering a life-threatening situation necessitating ICU admission. These acute complications are positively predicted by the degree of hypercortisolism, emphasizing the necessity for acute interventions aiming to reduce cortisol excess even before definitive disease cure is achieved.
format Online
Article
Text
id pubmed-7208937
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72089372020-05-13 MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes Schernthaner-Reiter, Marie Helene Siess, Christina Alexander, Micko Wolfsberger, Stefan Scheuba, Christian Riss, Philipp Knosp, Engelbert Kautzky-Willer, Alexandra Luger, Anton Vila, Greisa J Endocr Soc Neuroendocrinology and Pituitary Introduction Cushing’s syndrome is associated with significant chronic and acute comorbidities including acute thromboembolic and cardiovascular events. To date, there are no data on the prevalence and predictors of acute and perioperative complications in patients with active Cushing’s syndrome. Methods In a single-center cohort analysis we evaluate predictors and outcomes of acute, life-threatening and perioperative complications in patients with active biochemically verified Cushing’s syndrome attending our endocrine department between 1978 and 2016. Any medical complications necessitating hospitalization, including admission to intensive care units (ICUs), from the time of appearance of first symptoms of hypercortisolism until one year after biochemical remission by surgery (or where surgical remission was not achieved, during continuing follow-up) were recorded and classified. Baseline factors related to and predicting acute complications were tested using uni- and multivariate analysis. Results The study included 242 patients (m/f n=54/188) with Cushing’s syndrome (pituitary n=99, adrenal n=116, ectopic n=27), 14.0% of which had malignant disease. At least one acute complication was observed in 54.5% of patients; these included electrolyte disturbances (24.4%), infections (27.7%), thromboembolic events (14.9%), cardiac arrhythmias necessitating medical intervention (5.4%), hypertensive crises (8.7%), acute coronary events (3.3%) and cerebrovascular events (4.1%). At least one ICU admission (excluding post-surgical observance) was required in 13.2% of patients. The majority of complications occurred prior to surgery (60-90%); infections occurred pre- and postoperatively (51.7% vs 48.3%, respectively). Patients with ectopic Cushing’s syndrome demonstrated a higher likelihood of infection (p<0.001), hypokalemia (p<0.001) and ICU stays (p=0.009) compared to patients with pituitary or adrenal Cushing’s syndrome. Patients with diabetes mellitus at diagnosis (n=81) had a significantly higher frequency of infection (p<0.001), hypokalemia (p<0.001), hypertensive crises (p=0.004), acute coronary events (p=0.029), arrhythmias (p=0.025) and a higher likelihood of an ICU stay (p<0.001). The total number of acute complications and the number of days at ICU correlated positively with parameters of cortisol excess including urinary free cortisol and the time of hypercortisolism. Conclusion This cohort analysis identifies a significantly high prevalence of acute and perioperative complications in Cushing’s syndrome, with one in eight patients suffering a life-threatening situation necessitating ICU admission. These acute complications are positively predicted by the degree of hypercortisolism, emphasizing the necessity for acute interventions aiming to reduce cortisol excess even before definitive disease cure is achieved. Oxford University Press 2020-05-08 /pmc/articles/PMC7208937/ http://dx.doi.org/10.1210/jendso/bvaa046.789 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuroendocrinology and Pituitary
Schernthaner-Reiter, Marie Helene
Siess, Christina
Alexander, Micko
Wolfsberger, Stefan
Scheuba, Christian
Riss, Philipp
Knosp, Engelbert
Kautzky-Willer, Alexandra
Luger, Anton
Vila, Greisa
MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes
title MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes
title_full MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes
title_fullStr MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes
title_full_unstemmed MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes
title_short MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes
title_sort mon-318 acute, life-threatening and perioperative complications in cushing’s syndrome: predictors and outcomes
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208937/
http://dx.doi.org/10.1210/jendso/bvaa046.789
work_keys_str_mv AT schernthanerreitermariehelene mon318acutelifethreateningandperioperativecomplicationsincushingssyndromepredictorsandoutcomes
AT siesschristina mon318acutelifethreateningandperioperativecomplicationsincushingssyndromepredictorsandoutcomes
AT alexandermicko mon318acutelifethreateningandperioperativecomplicationsincushingssyndromepredictorsandoutcomes
AT wolfsbergerstefan mon318acutelifethreateningandperioperativecomplicationsincushingssyndromepredictorsandoutcomes
AT scheubachristian mon318acutelifethreateningandperioperativecomplicationsincushingssyndromepredictorsandoutcomes
AT rissphilipp mon318acutelifethreateningandperioperativecomplicationsincushingssyndromepredictorsandoutcomes
AT knospengelbert mon318acutelifethreateningandperioperativecomplicationsincushingssyndromepredictorsandoutcomes
AT kautzkywilleralexandra mon318acutelifethreateningandperioperativecomplicationsincushingssyndromepredictorsandoutcomes
AT lugeranton mon318acutelifethreateningandperioperativecomplicationsincushingssyndromepredictorsandoutcomes
AT vilagreisa mon318acutelifethreateningandperioperativecomplicationsincushingssyndromepredictorsandoutcomes